Indonesia’s pursuit of universal health coverage: challenges in selecting high-value healthcare and preventing waste

Policy Blog
This was an invited guest blog written by colleagues in Thailand’s Health Intervention and Technology Assessment Program. Health care technologies, including medicines, vaccines, and devices, contribute towards improved health outcomes but are also drivers of the rising costs of healthcare. Therefore, in the interest of sustainability it is essential to assess the value of these technologies on a regular basis. Indonesia, the fourth most populous country in the world, has a prime example of an evolving health system that is facing rising health care costs. This challenge, along with Indonesia’s transition from official development assistance for health and a budget deficit facing the country’s social insurance administration organization (called BPJS), which administers the national health insurance program, have made health technology assessment (HTA) a critically important tool. HTA can help…
Read More

Always the Bridesmaid…

Policy Blog
The following article was originally featured in the December 2018 issue of  The Medicine Maker magazine. The complete December 2018 issue of the magazine can be found here. You can download the PDF version of this article here ( Article_Always the Bridesmaid) Author: Gavin Yamey ( @GYamey) is the Director of the Center for Policy Impact in Global Health and a Professor of the Practice of Global Health and Public Policy at the Duke Global Health Institute.
Read More

Development Assistance for Health: 4 Key Developments to Watch for in 2019

Policy Blog
2018 has been a year of many firsts that could help to mobilize global health financing and improve collaboration among global health actors.  Among these firsts, the Global Financing Facility’s (GFF) first replenishment, China’s establishment of its new aid agency, and a global action plan uniting the leading health multilateral agencies together for accelerating progress towards the Sustainable Development Goals (SDGs) stand out. 2019 is also shaping up to be a crucial year for global health development assistance. Here are the top things I’ll be watching in the coming year: Replenishment Mania GFF kicked off the health replenishment cycle in Norway last month with somewhat disappointing results: donors agreed to provide $1 billion to the GFF, achieving half of its target of $2 billion. More pledges may roll in after the…
Read More

Donor Transitions From HIV Programs: What Is The Impact On Vulnerable Populations?

Policy Blog
This blog was originally published in Health Affairs Blog on December 14, 2018. The original version can be found here.  Many middle-income countries are transitioning away from donor-funded health programs in a range of areas including immunization, maternal and child health, tuberculosis, malaria, and HIV. Unless these donor exits are managed well, they could imperil the sustainability of the remarkable gains that have been achieved over the past two decades in fighting killer infectious diseases and maternal and child health conditions. Donor exits could particularly jeopardize gains in global HIV control. Countries and donors have spent more than $500 billion on HIV programs in low- and middle-income countries over the past two decades, but the gains from these investments are fragile. When donor funding for HIV programs ends, there is an especially acute…
Read More